MAZE
#2129
Maze Therapeutics, Inc. - Common Stock
27.2 2 USD
-0.02%
Market Price
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
Faixa anual
Mudança diária
-1.73%
Mudança mensal
+9.32%
Mudança em 6 meses
-1.59%
Mudança anual
-39.55%
Fechamento anterior
27.7 0
Open
27.5 4
Mínimo
26.9 5
Máximo
28.2 4
Financials
2026
Current report, 13 Aug 2026
Maze Therapeutics, Inc. current report, 13 August 2026
8-K
Current report, Q3 FY2026
Maze Therapeutics, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Maze Therapeutics, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Maze Therapeutics, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Maze Therapeutics, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Maze Therapeutics, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Maze Therapeutics, Inc. current report, Q1 FY2026
8-K